4e Conférence canadienne consensuelle sur le diagnostic et le traitement de la démence

Canadian Journal of Neurological Sciences

Volumn 39, Issue S5, 2012, Pages S1-S8

  Gauthier, S ^a   Patterson, C ^a   Chertkow, H ^a   Gordon, M ^a   Herrmann, N ^a   Rockwood, K ^a   Rosa Neto, P ^a   Soucy, J P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85022868612     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100015171     Document Type: Article

References (19)

1. Organizing Committee Canadian Consensus Conference on the Assessment of Dementia. Assessing Dementia the Canadian Consensus. CMAJ. 1991; 144(7):851–3. 2007235
2. Patterson C, Gauthier S, Bergman H, et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ. 1999; 160 Suppl: S1–15.
3. Chertkow H. Diagnosis and treatment of dementia: introduction. CMAJ. 2008; 178(3):316–21. 18227452
4. Patterson C, Feightner JW, Garcia A, et al. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ. 2008; 178: 548–56. 10.1503/cmaj.070796 18299540
5. Chertkow H, Massoud F, Nasreddine Z, et al. Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ. 2008; 178: 1273–85. 10.1503/cmaj.070797 18458258
6. Hogan DB, Bailey P, Black S, et al. Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. CMAJ. 2008; 179: 787–93. 10.1503/cmaj.070803 18838454
7. Hogan DB, Bailey P, Black S, et al. Diagnosis and treatment of dementia: 5. Non-pharmacologic and pharmacologic therapy for mild to moderate dementia. CMAJ. 2008; 179: 1019–26. 10.1503/cmaj.081103 18981443
8. Herrmann N, Gauthier S. Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease. CMAJ. 2008; 179: 1279–87. 10.1503/cmaj.070804 19047609
9. Feldman HH, Jacova C, Robillard A, et al. Diagnosis and treatment of dementia: 2. Diagnosis. CMAJ. 2008; 178: 825–36. 10.1503/cmaj.070798 18362376
10. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6: 734–46. 10.1016/S1474-4422(07)70178-3 17616482
11. Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol. 2010; 9: 1118–27. 10.1016/S1474-4422(10)70223-4 20934914
12. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging - Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011; 7: 263–9. 10.1016/j.jalz.2011.03.005 21514250
13. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging - Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011; 7: 270–9. 10.1016/j.jalz.2011.03.008 21514249
14. Sperling RA, Aisen P, Beckett L, et al. Toward defining the preclinical stages of Alzhheimer’s disease: recommendations from the National Institute on Aging - Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011; 7: 280–92. 10.1016/j.jalz.2011.03.003 21514248
15. Gauthier S, Patterson C, Gordon M, Soucy JP, Schubert F, Leuzy A. Commentary on “Recommendations from the National Institute on Aging - Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease”. Alzheimers Dement. 2011; 7: 330–3. 10.1016/j.jalz.2011.03.006 21575874
16. The AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003; 12: 18–23. 10.1136/qhc.12.1.18 12571340
17. Guyatt GH, Oxman AD, Vist GE, et al for the GRADE Working Group. GRADE; an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336: 924–6. 10.1136/bmj.39489.470347.AD 18436948
18. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for health care professionals from the American Heart Association/American Academy of Neurology. Stroke. 2011; 42: 2672–713. 10.1161/STR.0b013e3182299496 21778438
19. Wu L, Rosa-Neto P, Hsiung GY, et al. Early-onset familial Alzheimer’s disease (EOFAD). Can J Neurol Sci. 2012; 39: 436–45.